In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...

PISCATAWAY, N.J., April 14, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced its 2025 Environmental, Social, and Governance (ESG) Report, positioning the company at the forefront of ...

SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation ...

R&D Innovation to Lead the Future, Deepening Customer Value Creation From the performance during the 2023 reporting period, GenScript Group's overall development is optimistic, with each business ...

NANJING, China, Jan. 4, 2024 /PRNewswire/ -- GenScript Biotech, a global leader in life science research and manufacturing services, along with its subsidiaries GenScript ProBio and Legend Biotech, ...

Earnings call GenScript's 2025 revenue surged 61.4% YoY to $959.5M, with adjusted net profit up 285% to $230.3M, fueled by strong segment performance and a major licensing deal. Despite a non-cash ...

Analysts expect annual sales of Carvykti, Legend Biotech’s core cancer therapy, to peak at $7.3 billion With about $2 billion in cash reserves, Genscript isn’t under pressure to sell its 48% holding ...

Good day and thank you for standing by. Welcome to Genscript Biotech 2025 Interim Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, ...

GENSCRIPT BIOTECH (01548.HK) announced that its subsidiary Legend Biotech, pursuant to its collaboration and license agreement with Janssen Biotech, recorded net trade sales of app... Open a new ...

The share-price surge came as promising cancer trial data overshadowed continuing scrutiny of China's biotechnology sector by US lawmakers GenScript Biotech Holdings surged in Hong Kong after its ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Genscript Biotech (SEHK:1548) has seen the stock slip about ...